Molecular Partners Stock Target Price and Analyst Consensus
| MOLN Stock | USD 3.77 0.10 2.58% |
The current analyst and expert consensus on Molecular Partners is Buy, with only one strong buy opinion. The current projected Molecular Partners target price consensus is 10.28 with 3 analyst opinions. The most common way Molecular Partners analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Molecular Partners executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Molecular Partners. We encourage you to use your own analysis of Molecular Partners to validate this buy or sell advice. Molecular Partners buy-or-sell recommendation module provides average expert sentiment on the projected Molecular Partners target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Molecular Partners to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 9.35 | Highest Forecast 11.41 | Target Price 10.28 |
Molecular |
It's important to approach Molecular Partners' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Molecular Partners price targets
Molecular Partners' stock target price is an estimate of its future price, usually made by analysts. Using Molecular Partners' target price to determine if it is a suitable investment can be done through the following steps:- Look at Molecular Partners' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Molecular Partners' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Molecular Partners Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Molecular Partners is a key component of Molecular Partners valuation and have some predictive power on the future returns of a Molecular Partners.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Molecular Partners' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Adviser Favorites Invested few shares | |
 | Hedge Favorites Invested few shares | |
Check out Macroaxis Advice on Molecular Partners to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Molecular Stock analysis
When running Molecular Partners' price analysis, check to measure Molecular Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecular Partners is operating at the current time. Most of Molecular Partners' value examination focuses on studying past and present price action to predict the probability of Molecular Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecular Partners' price. Additionally, you may evaluate how the addition of Molecular Partners to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
The data published in Molecular Partners' official financial statements usually reflect Molecular Partners' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Molecular Partners. For example, before you start analyzing numbers published by Molecular accountants, it's critical to develop an understanding of what Molecular Partners' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Molecular Partners' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Molecular Partners' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Molecular Partners' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Molecular Partners AG. Please utilize our Beneish M Score to check the likelihood of Molecular Partners' management manipulating its earnings.